These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Renal effects of a urodilatin infusion in patients with liver cirrhosis, with and without ascites. Carstens J, Greisen J, Jensen KT, Vilstrup H, Pedersen EB. J Am Soc Nephrol; 1998 Aug; 9(8):1489-98. PubMed ID: 9697672 [Abstract] [Full Text] [Related]
13. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure. Moe GW, Canepa-Anson R, Armstrong PW. J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766 [Abstract] [Full Text] [Related]
14. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial. Mitrovic V, Lüss H, Nitsche K, Forssmann K, Maronde E, Fricke K, Forssmann WG, Meyer M. Am Heart J; 2005 Dec; 150(6):1239. PubMed ID: 16338265 [Abstract] [Full Text] [Related]
15. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation. Brenner P, Meyer M, Reichenspurner H, Meiser B, Müller R, Mentz P, Schulz-Knappe P, Uberbacher HJ, Kreuzer E, Uberführ P. Eur J Med Res; 1995 Dec 18; 1(3):137-43. PubMed ID: 9389675 [Abstract] [Full Text] [Related]
16. Renal effects of brain natriuretic peptide in patients with congestive heart failure. Jensen KT, Eiskjaer H, Carstens J, Pedersen EB. Clin Sci (Lond); 1999 Jan 18; 96(1):5-15. PubMed ID: 9857101 [Abstract] [Full Text] [Related]